Abiraterone in patients with metastatic castration-resistant prostate cancer progressing after docetaxel and MDV3100.
Ecaterina Ileana
No relevant relationships to disclose
Yohann Loriot
No relevant relationships to disclose
Laurence Albiges
No relevant relationships to disclose
Christophe Massard
No relevant relationships to disclose
Aurore Blesius
No relevant relationships to disclose
Mario Di Palma
No relevant relationships to disclose
Bernard J. Escudier
No relevant relationships to disclose
Pierre Blanchard
No relevant relationships to disclose
Alberto Bossi
No relevant relationships to disclose
Karim Fizazi
Consultant or Advisory Role - Astellas Pharma; Janssen-Cougar; Medivation